BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 26881510)

  • 21. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
    Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
    Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
    J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
    Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
    J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience.
    Pollock BE; Stafford SL; Link MJ; Garces YI; Foote RL
    Cancer; 2012 Feb; 118(4):1048-54. PubMed ID: 21773968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
    Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
    World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy after surgery for benign cerebral meningioma.
    Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
    Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
    Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
    J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
    Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
    J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
    Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
    Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
    J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
    Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
    World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
    Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
    Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical meningioma: a study of prognostic factors.
    Zaher A; Abdelbari Mattar M; Zayed DH; Ellatif RA; Ashamallah SA
    World Neurosurg; 2013 Nov; 80(5):549-53. PubMed ID: 23871812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
    Detti B; Scoccianti S; Di Cataldo V; Monteleone E; Cipressi S; Bordi L; Pellicanò G; Gadda D; Saieva C; Greto D; Pecchioli G; Buccoliero A; Ceroti M; Ammannati F; Biti G
    J Neurooncol; 2013 Dec; 115(3):421-7. PubMed ID: 24045968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of failure after stereotactic radiotherapy of intracranial meningioma.
    Askoxylakis V; Zabel-du Bois A; Schlegel W; Debus J; Huber P; Milker-Zabel S
    J Neurooncol; 2010 Jul; 98(3):367-72. PubMed ID: 20012910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.